DoseASSURE, Anti-TNF-α Drug
14 days
Electrochemiluminescence immunoassay (ECLIA)
Test Includes Adalimumab concentration, antiadalimumab antibody level, serial monitoring. Cause for Rejection: Plasma specimen received. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.
Accredited Laboratory Partner
Contact Technical Support
Measures serum levels of adalimumab and antibodies against it. Used to monitor biologic therapy in autoimmune conditions.
Serum
2 mL
Red-top tube or gel-barrier tube
No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider.
This test does not require any special collection or pre-analytical handling. Follow routine specimen collection protocols.
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |
| Frozen | 308 days |